Results 1 to 10 of about 42,703 (308)

Combination of Second-line Antirheumatic Drugs [PDF]

Annals of Medicine, 1997
Single drug therapy is often not satisfactory in the treatment of chronic arthritis. The combination of second-line antirheumatic drugs is therefore increasingly employed. Various strategies of combining drugs can be used, starting with combinations or adding agents in case of insufficient effect of single therapy.
Haagsma, C.J., Riel, P.L.C.M. van
openaire   +6 more sources

Adherence to the antirheumatic drugs: a systematic review and meta-analysis [PDF]

Frontiers in Medicine
IntroductionThis systematic review and meta-analysis aimed to analyze the adherence rate for conventional and biological disease-modifying antirheumatic drugs (DMARDs) utilizing different assessment measures.MethodA systematic literature search was ...
Nilay Aksoy, Nur Ozturk, Tamas Agh, Tamas Agh, Przemyslaw Kardas   +4 more
doaj   +2 more sources

Antirheumatic Drugs and the Risk of Tuberculosis [PDF]

Clinical Infectious Diseases, 2006
We aimed to quantify the rate of Mycobacterium tuberculosis disease (TB) among a cohort of patients with rheumatoid arthritis (RA) and to assess whether the independent use of disease-modifying antirheumatic drugs (DMARDs) is associated with the risk of developing TB.The study was performed using the PharMetrics Patient-Centric database (PharMetrics ...
Samy Suissa, Samy Suissa, Abbas Kezouh, Paul Brassard   +3 more
openaire   +4 more sources

The Safety of Antirheumatic Drugs [PDF]

Dtsch Arztebl Int, 2022
Drug therapy for rheumatic diseases has changed fundamentally in recent decades with the introduction of many new agents. As these drugs may have to be taken for many years, and many of them are of similar efficacy, their safety profiles play an important role in therapeutic decisionmaking.This review is based on pertinent literature retrieved by a ...
Mucke J, Simon H, Rüdiger Burmester G.
europepmc   +3 more sources

Risk of Herpes Zoster in Individuals on Biologics, DMARDS and/or Corticosteroids for Autoimmune Diseases:A Systematic Review and Meta-Analysis [PDF]

, 2016
Background: Studies examining the risk of herpes zoster (HZ) associated with immunosuppressants, such as biologics, non-biological disease modifying agents (nbDMARDs) or corticosteroids, have generated conflicting results.
Alarcón-Segovia, Bachelez, Bejarano, Bongartz, Braun, Brenner, Bresnihan, Cardiel, Che, Chen, Choy, Cohen, Cutolo, Dechartres, Dixon, Dixon, Dreiher, Egger, Emery, Emery, Fleischmann, Fleischmann, Furie, Furst, Galloway, Genovese, Genovese, Gupta, Gupta, Harpaz, Hayward, Higgins, Higgins, Hoes, Kameda, Kawai, Keystone, Kost, Kourbeti, Kremer, Kremer, Kremer, Kremer, Lal, Leonardi, Long, McDonald, Merrill, Moher, Moreland, Moutsopoulos, Nakajima, Nishimoto, Osterman, Oxman, Oxman, Papp, Pappas, Peto, Rutgeerts, Sampathkumar, Sandborn, Sandborn, Schiff, Schreiber, Segan, Shah, Singh, Smitten, Smolen, Smolen, Spittal, Strangfeld, Stroup, Sweeting, Takeuchi, Tanaka, Tanaka, van der Heijde, van Vollenhoven, Veetil, Weiner, Wells, Winthrop, Winthrop, Winthrop, Wolfe, Yamamoto, Yawn, Yawn, Youssef, Yun, Zhang, Zisman, Zorzela   +94 more
core   +3 more sources

Aphthous colitis induced by non-steroidal antirheumatic drugs

Swiss Medical Weekly, 2003
I Zuber-Jerger
doaj   +2 more sources

Disease-modifying antirheumatic drugs [PDF]

Nursing, 2010
Jennifer M. Belavic
openaire   +4 more sources

Repurposing haloperidol for the treatment of rheumatoid arthritis: an integrative approach using data mining techniques

Therapeutic Advances in Musculoskeletal Disease, 2021
Introduction: Treatment of rheumatoid arthritis (RA) has advanced with the introduction of biological disease-modifying antirheumatic drugs. However, more than 20% of patients with RA still have moderate or severe disease activity.
Chihiro Nakagawa, Satoshi Yokoyama, Kouichi Hosomi, Mitsutaka Takada   +3 more
doaj   +1 more source

COVID-19 Therapy: the Role of Antirheumatic Drugs

Антибиотики и Химиотерапия, 2021
Currently, the close attention of the medical and international community is still riveted on the novel coronavirus infection, which caused the pandemic in 2020.
M. A. Litvinova, N. V. Muravyeva, B. S. Belov   +2 more
doaj   +1 more source

12. Toxicity of antirheumatic drugs [PDF]

Medical Journal of Australia, 1997
Pharmacological treatments can have a major impact on the outcome of rheumatic diseases. To achieve the best results, individual treatment regimens comprising analgesic agents, non-steroidal anti-inflammatory drugs and disease-modifying antirheumatic drugs are used.
Lehmann, T., Day, R. O., Brooks, P. M.
openaire   +3 more sources